Inspection of the percentage of CD31+ areas (Fig. 3c) and CD8+ T-cells (Fig. 3d) within these tumors also revealed no significant differences, thus excluding the possibility that the differences observed in tumor growth (see Fig. 2e) were due to defects in angiogenesis or cytotoxic T cell infiltration. The gene discussed is CD8A; the disease is neoplasm.